Why the study?
Does 50 mg metoprolol tartrate provide a higher degree of acute beta1-blockade compared to 25 mg carvedilol in healthy subjects?
Does 50 mg metoprolol tartrate provide a higher degree of acute beta1-blockade compared to 25 mg carvedilol in healthy subjects?
In healthy subjects, acute administration of 50 mg metoprolol tartrate achieves a higher degree of beta1-blockade than 25 mg carvedilol.
Informs acute beta-blocker dosing decisions; extends comparative RCT evidence on beta1-blockade intensity.
Differential efficacy of immediate-release metoprolol tartrate and carvedilol in the treatment of congestive heart failure remains a subject of ongoing debate. The degree of beta1-blockade can be assessed by percentage reduction of exercise heart rate. Twelve healthy subjects underwent symptom-limited cardiopulmonary exercise testing repeated weekly and 2 hours after randomized, double-blind administration of 50 mg metoprolol tartrate vs 25 mg carvedilol. Baseline heart rate, heart rate at 40% and 70% peak O2 consumption, and maximal exercise were significantly blunted more by metoprolol tartrate than by carvedilol (P<.05 for all). Peak O2 consumption was significantly reduced by metoprolol tartrate (P<.03) but not by carvedilol (P=.054). The change in O2 consumption was significantly correlated with the degree of beta1-blockade (r =0.45; P<.05). In healthy subjects, a higher degree of beta1-blockade is achieved with 50 mg metoprolol tartrate compared with 25 mg carvedilol.
No takes yet. Share an insight, caveat, or question.
Billeh et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: